Drugs / Kangfupen
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT07065175 | Aug 2025 → Jan 2029 expected | radiation proctitis | Peking Union Medical College Hospital | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Kangfupen | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07065175 ↗ |
| Route | Other | “Kangfupen liquid dressing (50 mL/once daily) will be administered as retention enema” NCT07065175 ↗ |